Security key
05338F306
Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)
CUSIP: 05338F306
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 4,004
- Total 13F value
- $61,380
- Share change
- +1,461
- SEC-reported price per share
- $15.33
- Number of holders
- 11
- Value change
- +$22,396
- Number of buys
- 7
- Shares outstanding
- 53,624,847
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
11
Top holders
10
AVTX full security history
Ownership snapshot
Full 13F holder table
Avalo Therapeutics, Inc. SEC filings
Avalo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05338F306
Recent filing periods:
Ownership snapshot
Top reported holders of AVTX - Avalo Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Jul 2026
13D/G
13F
Lead comparable stake: 11%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
11%
Commodore Capital LP
9.9%
TCG Crossover GP II, LLC
7.9%
Deep Track Capital, LP
6.9%
BlackRock, Inc.
6.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
11%
Reported 13D/G
· 31 Jul 2026
|
$110,226,327
5,737,966 shares
|
+$12,251,178 | 31 Jul 2026 |
| Commodore Capital LP |
13D/G
13F
Company
|
9.9%
Reported 13D/G
· 11 Jun 2026
|
$90,336,311
5,721,109 shares
|
$0 | 11 Jun 2026 |
| TCG Crossover GP II, LLC |
13D/G
|
7.9%
Reported 13D/G
· 05 May 2026
|
$43,476,699
3,017,120 shares
|
$0 | 05 May 2026 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
6.9%
Reported 13D/G
· 30 Jun 2026
|
$69,348,100
3,610,000 shares
|
+$10,661,031 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.5%
Reported 13D/G
· 30 Jun 2026
|
$80,675,418
4,365,553 shares
|
— | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
6.3%
Reported 13D/G
· 30 Jun 2026
|
$66,910,332
3,483,099 shares
|
+$19,737,199 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
4,004
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
125
Q3 2026 holders
11
Holder diff
-114
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend